Joint Outcome Study

This study has been completed.
Sponsor:
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00207597
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

This study examines the progression of joint disease in children with hemophilia assigned to either standard treatment or enhanced therapy.


Condition
Hemophilia A

Study Type: Observational
Study Design: Observational Model: Natural History
Time Perspective: Longitudinal
Official Title: A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia

Resource links provided by NLM:


Further study details as provided by Centers for Disease Control and Prevention:

Estimated Enrollment: 64
Study Start Date: September 1995
Estimated Study Completion Date: August 2005
  Eligibility

Ages Eligible for Study:   1 Year to 30 Months
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosed with hemophilia A
  • factor level less than 2%

Exclusion Criteria:

  • More than 2 bleeds into the same joint
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00207597

Sponsors and Collaborators
Investigators
Principal Investigator: Marilyn J Manco-Johnson, MD University of Colorado, Denver
  More Information

No publications provided by Centers for Disease Control and Prevention

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00207597     History of Changes
Other Study ID Numbers: CDC-NCBDDD-1455, U27/CCU812106
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Hemophilia A
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on September 16, 2014